Android app on Google Play

Orexigen (OREX) Higher Again, Shares Now Up ~90% in June Following Arena (ARNA), Analyst Upgrade

June 29, 2012 9:48 AM EDT Send to a Friend
Investors just can't get enough Orexigen Therapeutics (Nasdaq: OREX) following the FDA decision on Arena Pharmaceutircals (Nasdaq: ARNA) lorcaserin Wednesday and JPMorgan upgrade Thursday. Shares are up an additional 7.6 percent Friday, pushing shares up about 90 percent for the month of June.

Stock volatility is up about 2 percent from Thursday's close.




You May Also Be Interested In


Related Categories

Insiders' Blog, Momentum Movers

Related Entities

JPMorgan

Add Your Comment